Branched polyethylene glycol for linking polymer residues to antibodies

Details for Australian Patent Application No. 2004305291 (hide)

Owner UCB Pharma S.A.

Inventors Norman, Timothy John

Agent Watermark

Pub. Number AU-B-2004305291

PCT Pub. Number WO2005/061005

Priority 0329825.4 23.12.03 GB

Filing date 14 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 24 June 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/061005 Priority application(s): WO2005/061005

14 February 2008 Assignment before Grant

  Celltech R&D Limited The application has been assigned to UCB Pharma S.A. 2005

24 June 2010 Application Accepted

  Published as AU-B-2004305291

21 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305293-Process for producing pellets for pharmaceutical compositions

2004305276-Immunostimulant composition comprising at least one Toll-like receptor 7 or Toll-like receptor 8 agonist and a Tolllike receptor 4 agonist